Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease

To compare growth in children with intestinal failure-associated liver disease (IFALD) who received a fish oil intravenous lipid emulsion (FOLE) to those who received a soybean oil intravenous lipid emulsion (SOLE).

Source: The Journal of Pediatrics - February 10, 2020 Category: Pediatrics Authors: Kathleen Gura, Muralidhar H. Premkumar, Kara L. Calkins, Mark Puder Tags: Original Article Source Type: research